African first ladies team up against female infertility

0
391

Some African first ladies have formed a coalition to fight infertility in women. This is under the auspices of “Merck More Than a Mother” initiative which is aimed at empowering infertile women through access to information, education and health and by changing mind-sets.

This powerful initiative supports governments in defining policies to enhance access to regulated, safe and effective fertility care. It defines interventions to break the stigma around infertile women and raises awareness about infertility prevention and management. In partnership with academia, ministries of health and international fertility societies, the initiative also provides medical education and training for healthcare providers and embryologists to build and advance fertility care capacity in Africa and developing countries.

With “Merck More than a mother”, we have initiated a cultural shift to de-stigmatize infertility on all levels: By improving awareness, training the skills of local experts, building advocacy in cooperation with decision makers and by supporting childless women in starting their own small business. It’s all about giving every woman the respect and the help she deserves to live a fulfilling life, with or without a child.

The Ambassadors of “Merck More Than a Mother” are: First Lady of Ghana, H.E. REBECCA AKUFO-ADDO; H.E. NEO JANE MASISI, The First Lady of Botswana; H.E. DENISE NKURUNZIZA, The First Lady of the Republic of Burundi; H.E. BRIGITTE TOUADERA, The First Lady of Central Africa Republic; H.E. HINDA DEBY ITNO, The First Lady of Chad; H.E. DJÈNÈ CONDÈ, The First Lady of Guinea-Conakry; H.E. FATOUMATTA BAH BARROW, The First Lady of Gambia; H.E. AISSATA ISSOUFOU MAHAMADOU, The First Lady of Niger; H.E. FATIMA MAADA BIO, The First Lady of Sierra Leone and H.E. ESTHER LUNGU, The First Lady of Zambia.

Also, part of the campaign is our Merck Embryology & Fertility Training Program, a three-month hands-on practical course in partnership with IRSI, Indonesia, IIRRH, India and Manipal Academy of Higher Education (Manipal University), India to establish the platform of fertility specialists across Africa and developing countries. Merck Foundation provided for more than 84 candidates, in clinical and practical training for fertility specialists and embryologists in more than 29 countries across Africa and Asia such as: Chad, Niger, Central African Republic, Cote D’Ivoire , Ghana, Ethiopia , Uganda, Kenya, Tanzania , Zambia , Nigeria, Benin, Mali, Burkina Fuso, Senegal, Guinea Conakry, Sierra Leone, Liberia, Cameron, Rwanda, Botswana,  DR Congo , Congo Brazzaville, Gambia , Nepal, Sri Lanka, Bangladesh, Myanmar and Cambodia.

Merck Foundation is making history in many African countries where they never had fertility specialists or specialized fertility clinics before ‘Merck More Than a Mother’ intervention, to train the first fertility specialists such as; in Sierra Leone, Liberia, The Gambia, Niger, Chad, Guinea, Ethiopia and Uganda.

About Merck Foundation:

The Merck Foundation (www.Merck-Foundation.com), established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website.   Please go to www.Merck-Foundation.com  to read more and/or register online to interact and exchange experience with our registered members.

About Merck:

Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 53,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smart phones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

$$